Feb 14, 2024 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Marksans Pharma 3Q FY24 conference call hosted by Elara Securities Private Limited. (Operator Instructions) Please note that this conference is being recorded.
And I now hand the conference over to Mr. Bino Pathiparampil from Elara Securities Private Limited. Thank you, and over to you, sir.
Bino Pathiparampil Elara Securities(India)Private Limited-Analyst
Hi, thank you, Aditya. Very good afternoon to all of you. This is Dr. Bino Pathiparampil from Elara Securities. I welcome you all to the quarter three FY24 earnings conference call of Marksans Pharma. Today we have with us on the call, Mark Saldanha, Founder and Managing Director, and Jitendra Sharma, Chief Financial Officer.
I hand over the call to the management for opening remarks. After that, we'll have a Q&A session. Over to you, Mark and Jitendra.
Mark Saldanha Marksans Pharma Limited-Chairman&MD
Thank you, Dr. Bino.
Q3 2024 Marksans Pharma Ltd Earnings Call Transcript
Feb 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers